SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-052558
Filing Date
2022-02-25
Accepted
2022-02-24 19:06:07
Documents
14
Period of Report
2022-02-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d290205d8k.htm   iXBRL 8-K 30448
2 EX-10.1 d290205dex101.htm EX-10.1 160352
  Complete submission text file 0001193125-22-052558.txt   382233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20220224.xsd EX-101.SCH 3908
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20220224_def.xml EX-101.DEF 13282
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20220224_lab.xml EX-101.LAB 21864
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20220224_pre.xml EX-101.PRE 14179
8 EXTRACTED XBRL INSTANCE DOCUMENT d290205d8k_htm.xml XML 5150
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 22673603
SIC: 2836 Biological Products, (No Diagnostic Substances)